Mel Mann, Patient Advocate, The World’s Longest Living Gleevec (Imatinib) and Tyrosine Kinase Inhibitor (TKI) Survivor, shared a post on Linkedin:
“It was a pleasure meeting CML expert, Ravi Bhatia, MD, division director of the UAB Medicine Hematology/Oncology Department, at the Blood Cancer United Conference.
He gave an excellent presentation on CML.”
More posts featuring CML.
